The division of surgical oncology is pleased to welcome Mautin Barry-Hundeyin, MD, to the UK College of Medicine Department of Surgery. Dr. Barry-Hundeyin joins the NCI-designated UK Markey Cancer Center as a surgical oncologist specializing in the management of hepatopancreatobiliary (HPB) and gastrointestinal (GI) malignancies.
Dr. Barry-Hundeyin attended Pennsylvania State University College of Medicine, Hershey, Pa., where she was inducted into the Alpha Omega Alpha (AOA) Honor Medical Society. She completed her general surgery training at Harvard Medical School/Beth Israel Deaconess Medical Center, winning numerous teaching awards.
She subsequently completed a post-doctoral research fellowship at New York University, where she published landmark papers in pancreatic cancer tumor immunology. Most recently, she completed a fellowship in Complex General Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York.
In addition to her clinical practice, Dr. Barry-Hundeyin will be developing a basic/translational research program studying innate immune regulation of the tumor microenvironment. The goal is to discover novel immunotherapeutics, thereby making meaningful advancements in the care of cancer patients.
She is married to a Kentucky native and they are excited to settle here in Lexington. In their free time, they enjoy hiking, eating at local restaurants, and rooting for the Bengals.
"We are thrilled that Dr. Barry-Hundeyin has joined our team. Her surgical expertise and translational research skills will strengthen and add depth to our UK cancer programs," said Division Chief of Surgical Oncology Dr. Joseph Kim.
Dr. Barry-Hundeyin officially begins her clinical practice at the University of Kentucky in October 2022.